Mdl-926 Is No Longer Accepting Claims For Disease Review
As of 12/15/2010, the MDL-926 is no longer accepting claims for disease review. If you are a registered claimant in the SF-DCT and have a Dow Corning implant, please contact our office for a free consultation: 800-529-6268.Breast implant class action lawyers helping with MDl-926 revised settlement deficiency claims.
If you are a registered claimant in the MDL 926 Revised Settlement Program, and have:
Already filed a Disease Claim prior to the 12/15/2010 deadline and received a deficiency notice in 2011 or 2012 we urge you to contact our office for a complimentary review of your claims.
Call or Email our office today to give us an opportunity to examine the Claims Offices’ ruling. We welcome the opportunity to help.
December 15, 2010 First Time Claim Filings:
The Revised Settlement Program (RSP) officially closed on December 15th 2010, and is no longer accepting any NEW Disease Claim filings. However, if you have received a deficiency letter in 2011 or 2012 in response to a claim filed timely by the December 15 deadline, we may be able to assist you in curing these deficiencies.
Please be advised, if you did in fact receive a deficiency letter from the Claims Office in 2011 or 2012 for your Long Term Benefit Disease Claim for General Connective Tissue Symptoms (GCTS), Scleroderma (SS), Systemic Lupus Erythematosus (SLE), and/or SEQ CHAPTER \h \r 1Polymositis/Dermatomyositis (PM) you only have one (1) year from the date of the deficiency letter to cure the required deficiencies for claim approval. SEQ CHAPTER \h \r 1Therefore if your GCTS, SLE, SS, and/or PM/DM claim(s) remains deficient on the date of your deficiency letter, it will be denied and you will not be eligible for GCTS, SLE, SS, and/or PM/DM benefits.